1. World Health Organization, Global Health Observatory (GHO) data. Available at: http://www.who.int/gho/hiv/en/.
2. Demonstration of Sustained Drug-Resistant Human Immunodeficiency Virus Type 1 Lineages Circulating among Treatment-Naïve Individuals
3. A.M. Wensing, N.M. van Maarseveen, and M. Nijhuis, Fifteen years of HIV protease inhibitors: Raising the barrier to resistance, Antiviral Res. 85 (2010), pp. 59–74.
4. Binding Free Energy Calculations of Nine FDA-approved Protease Inhibitors Against HIV-1 Subtype C I36T↑T Containing 100 Amino Acids Per Monomer
5. A. Wlodawer, M. Miller, M. Jaskolski, B.K. Sathyanarayana, E. Baldwin, I.T. Weber, L.M. Selk, L. Clawson, J. Schneider, and S.B. Kent, Conserved folding in retroviral proteases: Crystal structure of a synthetic HIV-1 protease, Science 245 (1989), pp. 616–621.